Omega Therapeutics, Inc.
OMGA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,444 | -$16,305 | -$20,129 | -$20,214 |
| Dep. & Amort. | $3,099 | $613 | $1,816 | $1,781 |
| Deferred Tax | $0 | $0 | $0 | -$12,192 |
| Stock-Based Comp. | $1,723 | $1,213 | $3,431 | $2,113 |
| Change in WC | -$2,406 | $1,795 | $3,065 | -$806 |
| Other Non-Cash | $13 | $12 | $2,129 | $12,228 |
| Operating Cash Flow | -$14,015 | -$12,672 | -$11,805 | -$17,090 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16 | -$396 | -$535 | -$1,111 |
| Net Acquisitions | $0 | $0 | $0 | $650 |
| Inv. Purchases | $0 | $0 | $0 | -$3,251 |
| Inv. Sales/Matur. | $0 | $0 | $5,000 | $2,601 |
| Other Inv. Act. | $0 | $0 | $5,000 | $3,251 |
| Investing Cash Flow | -$16 | -$396 | $4,465 | $2,140 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,446 | -$1,113 | -$1,092 | $0 |
| Stock Issued | $2 | $0 | $22 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | $22 | $1,625 |
| Financing Cash Flow | -$1,444 | -$1,113 | -$1,070 | $1,625 |
| Forex Effect | $0 | $0 | $0 | -$27,231 |
| Net Chg. in Cash | -$15,475 | -$14,181 | -$8,410 | -$13,325 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,193 | $60,374 | $68,443 | $81,768 |
| End Cash | $30,718 | $46,193 | $60,033 | $68,443 |
| Free Cash Flow | -$14,031 | -$13,068 | -$12,340 | -$18,201 |